Cargando…
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective indicator for the recurrence of PCa, its intended use as a screening marker for PCa is of considerable controversy. Recent research ef...
Autores principales: | Tonry, Claire L., Leacy, Emma, Raso, Cinzia, Finn, Stephen P., Armstrong, John, Pennington, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039561/ https://www.ncbi.nlm.nih.gov/pubmed/27438858 http://dx.doi.org/10.3390/diagnostics6030027 |
Ejemplares similares
-
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management
por: Tonry, Claire, et al.
Publicado: (2020) -
Probing the prostate tumour microenvironment II: Impact of hypoxia on a cell model of prostate cancer progression
por: Tonry, Claire, et al.
Publicado: (2017) -
Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression
por: Tonry, Claire, et al.
Publicado: (2017) -
Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LCMSA technical report
por: Staunton, L., et al.
Publicado: (2015) -
Multiplexed measurement of candidate blood protein biomarkers of heart failure
por: Tonry, Claire, et al.
Publicado: (2021)